Glacial Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-12-2024
- Paid Up Capital ₹ 1.00 M
as on 04-12-2024
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 3.39%
(FY 2020)
- Profit -7.77%
(FY 2020)
- Ebitda -90.16%
(FY 2020)
- Net Worth 19.88%
(FY 2020)
- Total Assets -2.25%
(FY 2020)
About Glacial Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ashutosh Kumar, Santosh Kumar, Arun Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232MH2007PTC172028
- Company No.
172028
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2007
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Glacial Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashutosh Kumar  | Director | 27-Jun-2007 | Current |
| Santosh Kumar | Director | 23-Jan-2009 | Current |
| Arun Kumar | Director | 23-Jan-2009 | Current |
| Bishwa Bharti | Director | 23-Jan-2009 | Current |
Financial Performance of Glacial Pharmaceuticals.
Glacial Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 3.39% increase. The company also saw a slight decrease in profitability, with a 7.77% decrease in profit. The company's net worth Soared by an impressive increase of 19.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glacial Pharmaceuticals?
In 2019, Glacial Pharmaceuticals had a promoter holding of 10.00% and a public holding of 90.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aparna Architect And Engicons Private LimitedActive 15 years 3 monthsSantosh Kumar, Arun Kumar and 1 more are mutual person
Ford Hospital And Research Center Private LimitedActive 17 years 8 monthsSantosh Kumar, Arun Kumar and 1 more are mutual person
Pda Life Science Private LimitedActive 4 years 5 monthsSantosh Kumar, Arun Kumar and 1 more are mutual person
- Innerva Realtors Private LimitedActive 11 years 5 months
Santosh Kumar, Arun Kumar and 1 more are mutual person
- Basford Education CouncilActive 2 years 10 months
Santosh Kumar, Arun Kumar and 1 more are mutual person
- Renovo Educational India Private LimitedActive 11 years 7 months
Santosh Kumar, Arun Kumar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Glacial Pharmaceuticals?
Unlock and access historical data on people associated with Glacial Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glacial Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glacial Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
